<DOC>
	<DOCNO>NCT00170859</DOCNO>
	<brief_summary>In study two immunosuppressive regimen ( everolimus combination cyclosporine microemulsion mycophenolate mofetil cyclosporine microemulsion ) reduce dose cyclosporine microemulsion compare maintenance heart transplant recipient impair renal function .</brief_summary>
	<brief_title>Everolimus Versus Mycophenolate Mofetil Combination With Reduced Dose Cyclosporine Microemulsion Maintenance Heart Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Recipients primary heart transplant Reduced renal function ( serum creatinine &gt; 1.7 ng/mL 2 month ) 6 month heart transplantation Patients current immunosuppressive therapy consist cyclosporine microemulsion mycophenolate mofetil Patients recipients multiple organ transplant Patients previously receive organ transplant Patients serum creatinine &gt; 3.5 mg/dl Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>everolimus</keyword>
	<keyword>cyclosporine microemulsion</keyword>
	<keyword>renal function</keyword>
</DOC>